Cabio Biotech (Wuhan) Co., Ltd. (688089.SS)
CNY 20.17
(-0.93%)
CNY 20.17
(-0.93%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.54 CNY | 42.11% |
| 2022 | 0.38 CNY | -50.65% |
| 2021 | 0.77 CNY | -1.28% |
| 2020 | 0.78 CNY | 11.43% |
| 2019 | 0.70 CNY | -9.09% |
| 2018 | 0.77 CNY | 48.08% |
| 2017 | 0.52 CNY | 40.54% |
| 2016 | 0.37 CNY | 131.25% |
| 2015 | 0.16 CNY | -61.9% |
| 2014 | 0.42 CNY | -20.75% |
| 2013 | 0.53 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | 0.09 CNY | -63.42% |
| 2024 Q2 | 0.26 CNY | 85.71% |
| 2024 Q1 | 0.14 CNY | -22.22% |
| 2023 Q3 | 0.15 CNY | 25.0% |
| 2023 Q4 | 0.18 CNY | 20.0% |
| 2023 Q2 | 0.12 CNY | 40.85% |
| 2023 Q1 | 0.09 CNY | 204.28% |
| 2023 FY | - CNY | 42.11% |
| 2022 Q4 | -0.08 CNY | -135.52% |
| 2022 FY | - CNY | -50.65% |
| 2022 Q3 | 0.23 CNY | 4.55% |
| 2022 Q2 | 0.22 CNY | 15.79% |
| 2022 Q1 | 0.19 CNY | -13.64% |
| 2021 Q3 | 0.27 CNY | -3.57% |
| 2021 Q2 | 0.28 CNY | 40.0% |
| 2021 Q4 | 0.22 CNY | -18.52% |
| 2021 Q1 | 0.20 CNY | 17.65% |
| 2021 FY | - CNY | -1.28% |
| 2020 Q3 | 0.23 CNY | -39.47% |
| 2020 Q1 | 0.15 CNY | -16.67% |
| 2020 Q2 | 0.38 CNY | 153.33% |
| 2020 FY | - CNY | 11.43% |
| 2020 Q4 | 0.17 CNY | -26.09% |
| 2019 Q4 | 0.18 CNY | -30.77% |
| 2019 FY | - CNY | -9.09% |
| 2019 Q3 | 0.26 CNY | -42.22% |
| 2019 Q2 | 0.45 CNY | 150.0% |
| 2019 Q1 | 0.18 CNY | -50.0% |
| 2018 FY | - CNY | 48.08% |
| 2018 Q4 | 0.36 CNY | 0.0% |
| 2017 FY | - CNY | 40.54% |
| 2016 FY | - CNY | 131.25% |
| 2015 FY | - CNY | -61.9% |
| 2014 FY | - CNY | -20.75% |
| 2013 FY | - CNY | 0.0% |